X4 Pharmaceuticals, Inc Quarterly Current Ratio in % from Q3 2018 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
X4 Pharmaceuticals, Inc quarterly Current Ratio history and growth rate from Q3 2018 to Q3 2024.
  • X4 Pharmaceuticals, Inc Current Ratio for the quarter ending September 30, 2024 was 505 %, a 13.5% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 505 -79 -13.5% Sep 30, 2024
Q2 2024 529 +32.7 +6.59% Jun 30, 2024
Q1 2024 537 +142 +36% Mar 31, 2024
Q4 2023 573 +189 +49.2% Dec 31, 2023
Q3 2023 584 +211 +56.6% Sep 30, 2023
Q2 2023 496 +41.4 +9.11% Jun 30, 2023
Q1 2023 395 -221 -35.9% Mar 31, 2023
Q4 2022 384 -324 -45.8% Dec 31, 2022
Q3 2022 373 -355 -48.8% Sep 30, 2022
Q2 2022 455 -298 -39.6% Jun 30, 2022
Q1 2022 616 -189 -23.5% Mar 31, 2022
Q4 2021 708 -224 -24.1% Dec 31, 2021
Q3 2021 727 -373 -33.9% Sep 30, 2021
Q2 2021 753 -455 -37.6% Jun 30, 2021
Q1 2021 805 -294 -26.7% Mar 31, 2021
Q4 2020 933 +233 +33.4% Dec 31, 2020
Q3 2020 1.1K +639 +139% Sep 30, 2020
Q2 2020 1.21K +826 +216% Jun 30, 2020
Q1 2020 1.1K +783 +248% Mar 31, 2020
Q4 2019 699 +205 +41.4% Dec 31, 2019
Q3 2019 461 -178 -27.8% Sep 30, 2019
Q2 2019 382 Jun 30, 2019
Q1 2019 316 Mar 31, 2019
Q4 2018 495 Dec 31, 2018
Q3 2018 639 Sep 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.